Reports
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States
Americas
Future Market Insights, Inc.
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States
MEA
Future Market Insights
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom
Asia Pacific
Future Market Insights
IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India
The global helicobacter pylori testing market is expected to accumulate US$ 173.1 Million in value by 2022-end. During the forecast period ranging from 2022 to 2032, a CAGR worth 7.4% has been projected for the market, with an expected closing value worth US$ 380.3 Million. During the 2016 to 2021 historical period, the industry grew at a value CAGR worth 6.2%.
Growing awareness of immunodiagnostics in developed countries like the United States & Germany and increasing product approvals boost the demand for Helicobacter Pylori Testing.
Attributes | Key Statistics |
---|---|
Global Helicobacter Pylori Testing Market CAGR (2022 to 2032) | 7.4% |
Anticipated Market Value (2022) | US$ 173.1 Million |
Global Helicobacter Pylori Testing Market (2032) | US$ 380.3 Million |
Global Helicobacter Pylori Testing Market Attraction | People's growing awareness of immunodiagnostics, rapid advances in technology and innovation, and increasing product approvals are anticipated to propel the global helicobacter pylori testing market forward. |
Helicobacter pylori testing is used to diagnose Helicobacter pylori infections in the upper small intestine and stomach. The helicobacter pylori test is also used to evaluate treatment efficacy. Peptic ulcers, stomach (gastric) cancer, and chronic gastritis can all be caused by helicobacter pylori.
Helicobacter pylori testing is used to determine whether a helicobacter pylori infection is causing an ulcer. There are various types of helicobacter pylori testing obtainable. Some of them require a stool or breath sample, while others are more invasive and require a tissue sample obtained via endoscopy.
The bacteria Helicobacter pylori grow in the digestive tract and have a proclivity to attack the stomach lining. Helicobacter pylori infections are usually harmless, but they are responsible for the vast majority of small intestine and stomach ulcers. Because it is the most common illness in humans, early detection is critical. According to CDC research, Helicobacter pylori causes more than 90% of duodenal ulcers and up to 80% of gastric ulcers.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The global helicobacter pylori testing industry is poised to increase consistently over the forecast period due to an aging population and an increase in the prevalence of infectious diseases and gastritis. People's growing awareness of immunodiagnostics, rapid advances in technology and innovation, and increasing product approvals are anticipated to propel the global helicobacter pylori testing market forward.
The advancement of newer innovations to enhance accuracy and precision has stemmed from a preference for non-invasive testing. Furthermore, non-invasive tests allow for multiple sample screenings at the same time, which a ects its acceptance rate. Reduced time, reduction of other infections during invasive testing, and less severe pain will all encourage more people to use non-invasive testing.
However, high test costs and a lack of awareness about helicobacter pylori testing are major factors restricting the growth of the global helicobacter pylori testing market.
Underdeveloped and developing countries face challenges related to a lack of healthcare resources. This results in limited access to healthcare services with insufficient facilities, which increases the likelihood of a lack of knowledge about such diseases and their diagnosis.
The market for Helicobacter pylori testing in North America is expected to take a turn for the better, attributed to the growing prevalence of H. pylori infections, rising awareness about disease diagnosis and treatment, and government initiatives to eradicate the incidence of infections.
The bacteria pose a high risk of stomach cancer, contributing to the existing disease burden, and are thus bound to grow the associated incidence and mortality among African Americans in the United States. Furthermore, advances in diagnostic technology and the inclusion of advanced healthcare infrastructure will fuel the country's growth. According to Future Market Insights, North America is likely to account for a 36.4% market share as of 2022.
According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), approximately half of the people over the age of 60 and 20% of people under the age of 40 are infected with Helicobacter Pylori in the United States. Furthermore, technological advancements in Helicobacter pylori diagnostics, as well as the presence of a well-established healthcare infrastructure, are fuelling the market's growth to a large extent.
Europe is thought to have the second-largest H. pylori testing market share, accumulating 32% revenue as of 2022. An important factor is the widespread utilization of antibiotics in many countries. In addition, rising investments and the presence of various key players are being evaluated to drive market growth.
The European market for helicobacter pylori testing is expected to be the second largest. The increasing patient pool intent on early detection of helicobacter pylori infection to avoid peptic ulcers is expected to aid market growth in the European region.
The role of H pylori in gastritis, peptic ulcers, and gastric cancer is now established, but research currently underway into possible associations with cardiovascular disease and several other conditions could guarantee a massive market in Europe for H pylori diagnostic tests and antimicrobial eradication therapy.
According to the National Institute for Health Research, the ubiquity of Helicobacter pylori is intense in most countries, including North European populations, where approximately one-third of adults are still infected, whereas, in South America, Asia, and south and east Europe, the prevalence is greater than 50%. Furthermore, Helicobacter pylori remain highly prevalent in immigrants from Helicobacter pylori-endemic countries in Europe. These factors are anticipated to propel the global helicobacter pylori testing market forward in Europe.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The swelling dispersion of start-ups in the Helicobacter Pylori Testing market has improved product quality and expanded global sales. Besides, to gain a competitive edge, new start-ups are working on innovative developments and launching new products such as:
Some key players in the Helicobacter Pylori Testing packaging market are Abbott, ADI/American Diagnostica, Agilent Technologies, Bio-Rad Laboratories, Inc., Helena Laboratories, Horiba, Takara Bio, EKF Diagnostics, Exalenz Bioscience Ltd. and Sekisui Diagnostics, LLC. A key development in the Helicobacter Pylori Testing Packaging market is as follows:
In July 2022, Bio-Rad released Platelia H. pylori IgG, an immuno-enzymatic assay for the qualitative determination of IgG antibodies. Serology provides a non-invasive, sensitive, and simple method for determining H. pylori infection. Platelia H. pylori IgG is an immunoenzymatic assay for determining the quality of IgG antibodies.
Report Attribute | Details |
---|---|
Growth Rate | CAGR of 7.4% from 2022 to 2032 |
Market Value in 2022 | US$ 173.1 Million |
Market Value in 2032 | US$ 380.3 Million |
Base Year for Estimation | 2021 |
Historical Period | 2016 to 2021 |
Forecast Period | 2022 to 2032 |
Quantitative Units | Revenue in US$ Million and CAGR from 2022 to 2032 |
Report Coverage | Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis |
Segments Covered |
|
Regions Covered |
|
Key Countries Profiled |
|
Key Companies Profiled |
|
Customization | Available Upon Request |
The global helicobacter pylori testing market is likely to value at US$ 173.1 Million in 2022.
The helicobacter pylori testing market is estimated to grow at a CAGR of 7.4% from 2022 to 2032.
The helicobacter pylori testing market is predicted to procure US$ 380.3 Million by 2032.
1. Executive Summary | Helicobacter Pylori Testing Market 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2016 to 2021 and Forecast, 2022 to 2032 4.1. Historical Market Size Value (US$ Million) Analysis, 2017 to 2021 4.2. Current and Future Market Size Value (US$ Million) Projections, 2022 to 2032 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Test Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Test Type, 2017 to 2021 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Test Type, 2022 to 2032 5.3.1. With Endoscopy 5.3.2. Histology 5.3.3. Rapid Urease Testing 5.3.4. Culture 5.3.5. PCR (Polymerase Chain Reaction) 5.3.6. Without Endoscopy 5.3.7. Stool/Faecal Antigen Test 5.3.8. Urea Breath Test 5.3.9. H. Pylori Antibody Testing 5.4. Y-o-Y Growth Trend Analysis By Test Type, 2017 to 2021 5.5. Absolute $ Opportunity Analysis By Test Type, 2022 to 2032 6. Global Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By End User 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By End User, 2017 to 2021 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2022 to 2032 6.3.1. Hospitals 6.3.2. Private Labs 6.3.3. Public Health Labs 6.3.4. Physician Offices 6.4. Y-o-Y Growth Trend Analysis By End User, 2017 to 2021 6.5. Absolute $ Opportunity Analysis By End User, 2022 to 2032 7. Global Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Region 7.1. Introduction 7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2017 to 2021 7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2022 to 2032 7.3.1. North America 7.3.2. Latin America 7.3.3. Europe 7.3.4. Asia Pacific 7.3.5. Middle East and Africa 7.4. Market Attractiveness Analysis By Region 8. North America Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country 8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032 8.2.1. By Country 8.2.1.1. United States of America 8.2.1.2. Canada 8.2.2. By Test Type 8.2.3. By End User 8.3. Market Attractiveness Analysis 8.3.1. By Country 8.3.2. By Test Type 8.3.3. By End User 8.4. Key Takeaways 9. Latin America Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country 9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032 9.2.1. By Country 9.2.1.1. Brazil 9.2.1.2. Mexico 9.2.1.3. Rest of Latin America 9.2.2. By Test Type 9.2.3. By End User 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Test Type 9.3.3. By End User 9.4. Key Takeaways 10. Europe Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032 10.2.1. By Country 10.2.1.1. Germany 10.2.1.2. United Kingdom 10.2.1.3. France 10.2.1.4. Spain 10.2.1.5. Italy 10.2.1.6. Rest of Europe 10.2.2. By Test Type 10.2.3. By End User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Test Type 10.3.3. By End User 10.4. Key Takeaways 11. Asia Pacific Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032 11.2.1. By Country 11.2.1.1. China 11.2.1.2. Japan 11.2.1.3. South Korea 11.2.1.4. India 11.2.1.5. Malaysia 11.2.1.6. Singapore 11.2.1.7. Australia 11.2.1.8. New Zealand 11.2.1.9. Rest of Asia-Pacific 11.2.2. By Test Type 11.2.3. By End User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Test Type 11.3.3. By End User 11.4. Key Takeaways 12. Middle East and Africa Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032 12.2.1. By Country 12.2.1.1. GCC Countries 12.2.1.2. South Africa 12.2.1.3. Israel 12.2.1.4. Rest of Middle East and Africa 12.2.2. By Test Type 12.2.3. By End User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Test Type 12.3.3. By End User 12.4. Key Takeaways 13. Key Countries Market Analysis 13.1. United States of America 13.1.1. Pricing Analysis 13.1.2. Market Share Analysis, 2021 13.1.2.1. By Test Type 13.1.2.2. By End User 13.2. Canada 13.2.1. Pricing Analysis 13.2.2. Market Share Analysis, 2021 13.2.2.1. By Test Type 13.2.2.2. By End User 13.3. Brazil 13.3.1. Pricing Analysis 13.3.2. Market Share Analysis, 2021 13.3.2.1. By Test Type 13.3.2.2. By End User 13.4. Mexico 13.4.1. Pricing Analysis 13.4.2. Market Share Analysis, 2021 13.4.2.1. By Test Type 13.4.2.2. By End User 13.5. Germany 13.5.1. Pricing Analysis 13.5.2. Market Share Analysis, 2021 13.5.2.1. By Test Type 13.5.2.2. By End User 13.6. United Kingdom 13.6.1. Pricing Analysis 13.6.2. Market Share Analysis, 2021 13.6.2.1. By Test Type 13.6.2.2. By End User 13.7. France 13.7.1. Pricing Analysis 13.7.2. Market Share Analysis, 2021 13.7.2.1. By Test Type 13.7.2.2. By End User 13.8. Spain 13.8.1. Pricing Analysis 13.8.2. Market Share Analysis, 2021 13.8.2.1. By Test Type 13.8.2.2. By End User 13.9. Italy 13.9.1. Pricing Analysis 13.9.2. Market Share Analysis, 2021 13.9.2.1. By Test Type 13.9.2.2. By End User 13.10. China 13.10.1. Pricing Analysis 13.10.2. Market Share Analysis, 2021 13.10.2.1. By Test Type 13.10.2.2. By End User 13.11. Japan 13.11.1. Pricing Analysis 13.11.2. Market Share Analysis, 2021 13.11.2.1. By Test Type 13.11.2.2. By End User 13.12. South Korea 13.12.1. Pricing Analysis 13.12.2. Market Share Analysis, 2021 13.12.2.1. By Test Type 13.12.2.2. By End User 13.13. Malaysia 13.13.1. Pricing Analysis 13.13.2. Market Share Analysis, 2021 13.13.2.1. By Test Type 13.13.2.2. By End User 13.14. Singapore 13.14.1. Pricing Analysis 13.14.2. Market Share Analysis, 2021 13.14.2.1. By Test Type 13.14.2.2. By End User 13.15. Australia 13.15.1. Pricing Analysis 13.15.2. Market Share Analysis, 2021 13.15.2.1. By Test Type 13.15.2.2. By End User 13.16. New Zealand 13.16.1. Pricing Analysis 13.16.2. Market Share Analysis, 2021 13.16.2.1. By Test Type 13.16.2.2. By End User 13.17. GCC Countries 13.17.1. Pricing Analysis 13.17.2. Market Share Analysis, 2021 13.17.2.1. By Test Type 13.17.2.2. By End User 13.18. South Africa 13.18.1. Pricing Analysis 13.18.2. Market Share Analysis, 2021 13.18.2.1. By Test Type 13.18.2.2. By End User 13.19. Israel 13.19.1. Pricing Analysis 13.19.2. Market Share Analysis, 2021 13.19.2.1. By Test Type 13.19.2.2. By End User 14. Market Structure Analysis 14.1. Competition Dashboard 14.2. Competition Benchmarking 14.3. Market Share Analysis of Top Players 14.3.1. By Regional 14.3.2. By Test Type 14.3.3. By End User 15. Competition Analysis 15.1. Competition Deep Dive 15.1.1. Abbott 15.1.1.1. Overview 15.1.1.2. Product Portfolio 15.1.1.3. Profitability by Market Segments 15.1.1.4. Sales Footprint 15.1.1.5. Strategy Overview 15.1.1.5.1. Marketing Strategy 15.1.2. ADI/American Diagnostica 15.1.2.1. Overview 15.1.2.2. Product Portfolio 15.1.2.3. Profitability by Market Segments 15.1.2.4. Sales Footprint 15.1.2.5. Strategy Overview 15.1.2.5.1. Marketing Strategy 15.1.3. Agilent Technologies 15.1.3.1. Overview 15.1.3.2. Product Portfolio 15.1.3.3. Profitability by Market Segments 15.1.3.4. Sales Footprint 15.1.3.5. Strategy Overview 15.1.3.5.1. Marketing Strategy 15.1.4. Bio-Rad Laboratories Inc. 15.1.4.1. Overview 15.1.4.2. Product Portfolio 15.1.4.3. Profitability by Market Segments 15.1.4.4. Sales Footprint 15.1.4.5. Strategy Overview 15.1.4.5.1. Marketing Strategy 15.1.5. Helena Laboratories 15.1.5.1. Overview 15.1.5.2. Product Portfolio 15.1.5.3. Profitability by Market Segments 15.1.5.4. Sales Footprint 15.1.5.5. Strategy Overview 15.1.5.5.1. Marketing Strategy 15.1.6. Horiba 15.1.6.1. Overview 15.1.6.2. Product Portfolio 15.1.6.3. Profitability by Market Segments 15.1.6.4. Sales Footprint 15.1.6.5. Strategy Overview 15.1.6.5.1. Marketing Strategy 15.1.7. Takara Bio 15.1.7.1. Overview 15.1.7.2. Product Portfolio 15.1.7.3. Profitability by Market Segments 15.1.7.4. Sales Footprint 15.1.7.5. Strategy Overview 15.1.7.5.1. Marketing Strategy 15.1.8. EKF Diagnostics 15.1.8.1. Overview 15.1.8.2. Product Portfolio 15.1.8.3. Profitability by Market Segments 15.1.8.4. Sales Footprint 15.1.8.5. Strategy Overview 15.1.8.5.1. Marketing Strategy 15.1.9. Exalenz Bioscience Ltd. 15.1.9.1. Overview 15.1.9.2. Product Portfolio 15.1.9.3. Profitability by Market Segments 15.1.9.4. Sales Footprint 15.1.9.5. Strategy Overview 15.1.9.5.1. Marketing Strategy 15.1.10. Sekisui Diagnostics 15.1.10.1. Overview 15.1.10.2. Product Portfolio 15.1.10.3. Profitability by Market Segments 15.1.10.4. Sales Footprint 15.1.10.5. Strategy Overview 15.1.10.5.1. Marketing Strategy 16. Assumptions & Acronyms Used 17. Research Methodology
Table 1: Global Market Value (US$ Million) Forecast by Region, 2016 to 2032 Table 2: Global Market Value (US$ Million) Forecast by Test Type, 2016 to 2032 Table 3: Global Market Value (US$ Million) Forecast by End User, 2016 to 2032 Table 4: North America Market Value (US$ Million) Forecast by Country, 2016 to 2032 Table 5: North America Market Value (US$ Million) Forecast by Test Type, 2016 to 2032 Table 6: North America Market Value (US$ Million) Forecast by End User, 2016 to 2032 Table 7: Latin America Market Value (US$ Million) Forecast by Country, 2016 to 2032 Table 8: Latin America Market Value (US$ Million) Forecast by Test Type, 2016 to 2032 Table 9: Latin America Market Value (US$ Million) Forecast by End User, 2016 to 2032 Table 10: Europe Market Value (US$ Million) Forecast by Country, 2016 to 2032 Table 11: Europe Market Value (US$ Million) Forecast by Test Type, 2016 to 2032 Table 12: Europe Market Value (US$ Million) Forecast by End User, 2016 to 2032 Table 13: Asia Pacific Market Value (US$ Million) Forecast by Country, 2016 to 2032 Table 14: Asia Pacific Market Value (US$ Million) Forecast by Test Type, 2016 to 2032 Table 15: Asia Pacific Market Value (US$ Million) Forecast by End User, 2016 to 2032 Table 16: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2016 to 2032 Table 17: Middle East and Africa Market Value (US$ Million) Forecast by Test Type, 2016 to 2032 Table 18: Middle East and Africa Market Value (US$ Million) Forecast by End User, 2016 to 2032
Figure 1: Global Market Value (US$ Million) by Test Type, 2022 to 2032 Figure 2: Global Market Value (US$ Million) by End User, 2022 to 2032 Figure 3: Global Market Value (US$ Million) by Region, 2022 to 2032 Figure 4: Global Market Value (US$ Million) Analysis by Region, 2016 to 2032 Figure 5: Global Market Value Share (%) and BPS Analysis by Region, 2022 to 2032 Figure 6: Global Market Y-o-Y Growth (%) Projections by Region, 2022 to 2032 Figure 7: Global Market Value (US$ Million) Analysis by Test Type, 2016 to 2032 Figure 8: Global Market Value Share (%) and BPS Analysis by Test Type, 2022 to 2032 Figure 9: Global Market Y-o-Y Growth (%) Projections by Test Type, 2022 to 2032 Figure 10: Global Market Value (US$ Million) Analysis by End User, 2016 to 2032 Figure 11: Global Market Value Share (%) and BPS Analysis by End User, 2022 to 2032 Figure 12: Global Market Y-o-Y Growth (%) Projections by End User, 2022 to 2032 Figure 13: Global Market Attractiveness by Test Type, 2022 to 2032 Figure 14: Global Market Attractiveness by End User, 2022 to 2032 Figure 15: Global Market Attractiveness by Region, 2022 to 2032 Figure 16: North America Market Value (US$ Million) by Test Type, 2022 to 2032 Figure 17: North America Market Value (US$ Million) by End User, 2022 to 2032 Figure 18: North America Market Value (US$ Million) by Country, 2022 to 2032 Figure 19: North America Market Value (US$ Million) Analysis by Country, 2016 to 2032 Figure 20: North America Market Value Share (%) and BPS Analysis by Country, 2022 to 2032 Figure 21: North America Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032 Figure 22: North America Market Value (US$ Million) Analysis by Test Type, 2016 to 2032 Figure 23: North America Market Value Share (%) and BPS Analysis by Test Type, 2022 to 2032 Figure 24: North America Market Y-o-Y Growth (%) Projections by Test Type, 2022 to 2032 Figure 25: North America Market Value (US$ Million) Analysis by End User, 2016 to 2032 Figure 26: North America Market Value Share (%) and BPS Analysis by End User, 2022 to 2032 Figure 27: North America Market Y-o-Y Growth (%) Projections by End User, 2022 to 2032 Figure 28: North America Market Attractiveness by Test Type, 2022 to 2032 Figure 29: North America Market Attractiveness by End User, 2022 to 2032 Figure 30: North America Market Attractiveness by Country, 2022 to 2032 Figure 31: Latin America Market Value (US$ Million) by Test Type, 2022 to 2032 Figure 32: Latin America Market Value (US$ Million) by End User, 2022 to 2032 Figure 33: Latin America Market Value (US$ Million) by Country, 2022 to 2032 Figure 34: Latin America Market Value (US$ Million) Analysis by Country, 2016 to 2032 Figure 35: Latin America Market Value Share (%) and BPS Analysis by Country, 2022 to 2032 Figure 36: Latin America Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032 Figure 37: Latin America Market Value (US$ Million) Analysis by Test Type, 2016 to 2032 Figure 38: Latin America Market Value Share (%) and BPS Analysis by Test Type, 2022 to 2032 Figure 39: Latin America Market Y-o-Y Growth (%) Projections by Test Type, 2022 to 2032 Figure 40: Latin America Market Value (US$ Million) Analysis by End User, 2016 to 2032 Figure 41: Latin America Market Value Share (%) and BPS Analysis by End User, 2022 to 2032 Figure 42: Latin America Market Y-o-Y Growth (%) Projections by End User, 2022 to 2032 Figure 43: Latin America Market Attractiveness by Test Type, 2022 to 2032 Figure 44: Latin America Market Attractiveness by End User, 2022 to 2032 Figure 45: Latin America Market Attractiveness by Country, 2022 to 2032 Figure 46: Europe Market Value (US$ Million) by Test Type, 2022 to 2032 Figure 47: Europe Market Value (US$ Million) by End User, 2022 to 2032 Figure 48: Europe Market Value (US$ Million) by Country, 2022 to 2032 Figure 49: Europe Market Value (US$ Million) Analysis by Country, 2016 to 2032 Figure 50: Europe Market Value Share (%) and BPS Analysis by Country, 2022 to 2032 Figure 51: Europe Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032 Figure 52: Europe Market Value (US$ Million) Analysis by Test Type, 2016 to 2032 Figure 53: Europe Market Value Share (%) and BPS Analysis by Test Type, 2022 to 2032 Figure 54: Europe Market Y-o-Y Growth (%) Projections by Test Type, 2022 to 2032 Figure 55: Europe Market Value (US$ Million) Analysis by End User, 2016 to 2032 Figure 56: Europe Market Value Share (%) and BPS Analysis by End User, 2022 to 2032 Figure 57: Europe Market Y-o-Y Growth (%) Projections by End User, 2022 to 2032 Figure 58: Europe Market Attractiveness by Test Type, 2022 to 2032 Figure 59: Europe Market Attractiveness by End User, 2022 to 2032 Figure 60: Europe Market Attractiveness by Country, 2022 to 2032 Figure 61: Asia Pacific Market Value (US$ Million) by Test Type, 2022 to 2032 Figure 62: Asia Pacific Market Value (US$ Million) by End User, 2022 to 2032 Figure 63: Asia Pacific Market Value (US$ Million) by Country, 2022 to 2032 Figure 64: Asia Pacific Market Value (US$ Million) Analysis by Country, 2016 to 2032 Figure 65: Asia Pacific Market Value Share (%) and BPS Analysis by Country, 2022 to 2032 Figure 66: Asia Pacific Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032 Figure 67: Asia Pacific Market Value (US$ Million) Analysis by Test Type, 2016 to 2032 Figure 68: Asia Pacific Market Value Share (%) and BPS Analysis by Test Type, 2022 to 2032 Figure 69: Asia Pacific Market Y-o-Y Growth (%) Projections by Test Type, 2022 to 2032 Figure 70: Asia Pacific Market Value (US$ Million) Analysis by End User, 2016 to 2032 Figure 71: Asia Pacific Market Value Share (%) and BPS Analysis by End User, 2022 to 2032 Figure 72: Asia Pacific Market Y-o-Y Growth (%) Projections by End User, 2022 to 2032 Figure 73: Asia Pacific Market Attractiveness by Test Type, 2022 to 2032 Figure 74: Asia Pacific Market Attractiveness by End User, 2022 to 2032 Figure 75: Asia Pacific Market Attractiveness by Country, 2022 to 2032 Figure 76: Middle East and Africa Market Value (US$ Million) by Test Type, 2022 to 2032 Figure 77: Middle East and Africa Market Value (US$ Million) by End User, 2022 to 2032 Figure 78: Middle East and Africa Market Value (US$ Million) by Country, 2022 to 2032 Figure 79: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2016 to 2032 Figure 80: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2022 to 2032 Figure 81: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032 Figure 82: Middle East and Africa Market Value (US$ Million) Analysis by Test Type, 2016 to 2032 Figure 83: Middle East and Africa Market Value Share (%) and BPS Analysis by Test Type, 2022 to 2032 Figure 84: Middle East and Africa Market Y-o-Y Growth (%) Projections by Test Type, 2022 to 2032 Figure 85: Middle East and Africa Market Value (US$ Million) Analysis by End User, 2016 to 2032 Figure 86: Middle East and Africa Market Value Share (%) and BPS Analysis by End User, 2022 to 2032 Figure 87: Middle East and Africa Market Y-o-Y Growth (%) Projections by End User, 2022 to 2032 Figure 88: Middle East and Africa Market Attractiveness by Test Type, 2022 to 2032 Figure 89: Middle East and Africa Market Attractiveness by End User, 2022 to 2032 Figure 90: Middle East and Africa Market Attractiveness by Country, 2022 to 2032
Recommendations
Explore Healthcare Insights
View Reports